Nanoparticles with Active Targeting Ability and Acid Responsiveness for an Enhanced Antitumor Effect of Docetaxel
Biomacromolecules · 2024
DOI: 10.1021/acs.biomac.3c00922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2024. Verfasst von Chengcheng Ouyang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing Tech University, Nanjing 211816, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Jiangsu National Synergistic Innovation Center for Advanced Materials, Science and Technology Support Program of Jiangsu Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nanjing Tech University, Nanjing 211816, China.
Förderung
- Jiangsu National Synergistic Innovation Center for Advanced Materials
- Science and Technology Support Program of Jiangsu Province
Zitieren
APA
Ouyang, C., Zhang, W., Nie, J., Yu, L., Liu, J., Ren, L., & Chen, G. (2024). Nanoparticles with Active Targeting Ability and Acid Responsiveness for an Enhanced Antitumor Effect of Docetaxel. Biomacromolecules. https://doi.org/10.1021/acs.biomac.3c00922
Vancouver
Ouyang C, Zhang W, Nie J, Yu L, Liu J, Ren L, et al. Nanoparticles with Active Targeting Ability and Acid Responsiveness for an Enhanced Antitumor Effect of Docetaxel. Biomacromolecules. 2024. doi:10.1021/acs.biomac.3c00922
BibTeX
@article{Ouyang2024,
author = {Ouyang, Chengcheng and Zhang, Wei and Nie, Junfang and Yu, Luting and Liu, Jia and Ren, Lili and Chen, Guoguang},
title = {Nanoparticles with Active Targeting Ability and Acid Responsiveness for an Enhanced Antitumor Effect of Docetaxel},
journal = {Biomacromolecules},
year = {2024},
doi = {10.1021/acs.biomac.3c00922}
}
EUVIMED